Spero Therapeutics Inc
NASDAQ:SPRO
Spero Therapeutics Inc
NASDAQ:SPRO
Price:
2.67
USD
-3.96%
Market Closed
Market Cap:
$150.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Spero Therapeutics Inc
NASDAQ:SPRO
|
US |
|
China Automotive Systems Inc
NASDAQ:CAAS
|
CN |
|
B
|
BoardWare Intelligence Technology Ltd
HKEX:1204
|
MO |
|
Bragg Gaming Group Inc
TSX:BRAG
|
CA |
|
Suburban Propane Partners LP
NYSE:SPH
|
US |
|
Destiny Media Technologies Inc
OTC:DSNY
|
CA |
|
Komatsu Ltd
F:KOMA
|
JP |
|
Bike24 Holding AG
XETRA:BIKE
|
DE |
|
A
|
Accent Resources NL
ASX:ACS
|
AU |
Balance Sheet
Balance Sheet Decomposition
Spero Therapeutics Inc
Spero Therapeutics Inc
Balance Sheet Decomposition is not available for
Spero Therapeutics Inc
Spero Therapeutics Inc
Balance Sheet
Spero Therapeutics Inc
Spero Therapeutics Inc
Currency: USD
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & Cash Equivalents |
6
|
10
|
87
|
34
|
30
|
85
|
113
|
109
|
76
|
53
|
40
|
|
| Cash Equivalents |
6
|
10
|
87
|
34
|
30
|
85
|
113
|
109
|
76
|
53
|
40
|
|
| Short-Term Investments |
0
|
0
|
0
|
81
|
52
|
42
|
34
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
3
|
1
|
9
|
6
|
3
|
1
|
51
|
52
|
25
|
|
| Other Current Assets |
0
|
1
|
2
|
8
|
5
|
6
|
9
|
3
|
4
|
2
|
2
|
|
| Total Current Assets |
6
|
12
|
92
|
124
|
95
|
139
|
158
|
114
|
131
|
107
|
67
|
|
| PP&E Net |
1
|
2
|
1
|
3
|
7
|
9
|
8
|
6
|
4
|
3
|
1
|
|
| PP&E Gross |
1
|
2
|
1
|
3
|
7
|
9
|
8
|
6
|
4
|
3
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
1
|
1
|
2
|
2
|
3
|
3
|
4
|
4
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
47
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
2
|
4
|
5
|
6
|
6
|
0
|
0
|
0
|
|
| Total Assets |
7
N/A
|
14
+92%
|
94
+578%
|
129
+38%
|
106
-18%
|
154
+45%
|
171
+11%
|
125
-27%
|
182
+46%
|
111
-39%
|
69
-38%
|
|
| Liabilities | ||||||||||||
| Accounts Payable |
2
|
1
|
4
|
4
|
4
|
1
|
1
|
1
|
1
|
7
|
1
|
|
| Accrued Liabilities |
1
|
3
|
4
|
8
|
23
|
13
|
16
|
11
|
8
|
19
|
8
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
4
|
3
|
0
|
1
|
0
|
0
|
2
|
10
|
28
|
22
|
1
|
|
| Total Current Liabilities |
6
|
7
|
8
|
12
|
27
|
14
|
19
|
22
|
37
|
49
|
9
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
48
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
1
|
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
1
|
1
|
0
|
1
|
5
|
7
|
16
|
27
|
38
|
15
|
1
|
|
| Total Liabilities |
7
N/A
|
4
-49%
|
9
+147%
|
14
+52%
|
32
+133%
|
21
-32%
|
83
+287%
|
49
-41%
|
75
+54%
|
64
-15%
|
10
-85%
|
|
| Equity | ||||||||||||
| Common Stock |
18
|
56
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
18
|
45
|
97
|
139
|
199
|
278
|
368
|
414
|
391
|
460
|
451
|
|
| Additional Paid In Capital |
0
|
0
|
181
|
254
|
274
|
410
|
456
|
490
|
498
|
506
|
510
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
10
+5 000%
|
85
+729%
|
116
+37%
|
75
-35%
|
132
+77%
|
88
-33%
|
76
-14%
|
107
+41%
|
46
-57%
|
59
+28%
|
|
| Total Liabilities & Equity |
7
N/A
|
14
+92%
|
94
+578%
|
129
+38%
|
106
-18%
|
154
+45%
|
171
+11%
|
125
-27%
|
182
+46%
|
111
-39%
|
69
-38%
|
|
| Shares Outstanding | ||||||||||||
| Common Shares Outstanding |
14
|
14
|
14
|
17
|
19
|
29
|
32
|
53
|
53
|
55
|
56
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
3
|
3
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
